{"result": "(\"entity\"<|>DIABETES<|>GEO<|>Diabetes is a chronic health condition that affects how the body processes blood sugar (glucose) and is associated with various complications, including diabetic retinopathy.)\n##\n(\"entity\"<|>DIABETIC MACULAR EDEMA<|>EVENT<|>Diabetic macular edema is a condition that occurs when fluid accumulates in the macula due to diabetic retinopathy, leading to vision problems.)\n##\n(\"entity\"<|>DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP<|>ORGANIZATION<|>The Diabetes Control and Complications Trial Research Group is a collaborative group that conducted research on the effects of diabetes management on complications, including retinopathy.)\n##\n(\"relationship\"<|>DIABETIC RETINOPATHY<|>DIABETIC MACULAR EDEMA<|>Diabetic macular edema is a complication that arises from diabetic retinopathy, affecting vision<|>8)\n##\n(\"relationship\"<|>DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP<|>DIABETES CARE<|>The Diabetes Control and Complications Trial Research Group has published findings in Diabetes Care regarding diabetes management and its complications<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Care. 2019;42(Suppl 1):S124-38.\n                                                                                                                                                         •  Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Retinopathy in young-onset diabetic patients. Diabetes Care. 1985;8: 311-5.\n           RDNP moderada              Otros hallazgos además de los microaneurismas, pero menos que en la grave\n                                      Algunos de los siguientes:\n           RDNP grave                 • 20 o más hemorragias en cuatro cuadrantes                                                                    45  ¿Cuál de los siguientes enunciados es cierto respecto a la retinopatía diabética?\n                                      • Arrosariamiento venoso en dos o más cuadrantes\n                                      • Anomalías vasculares intrarretinianas prominentes en uno o más cuadrantes                                        A. La principal causa de pérdida de visión en la retinopatía no proliferativa es el edema macular.\n                                      Uno o más de los siguientes:                                                                                       B. El edema macular no aparece en la retinopatía no proliferativa.\n           RDP                        • Neovascularización                                                                                               C. El embarazo no es un factor de riesgo para el empeoramiento de la retinopatía diabética.\n                                      • Hemorragia vítrea o prerretiniana                                                                                D.   Los tres enunciados son falsos.\n         Adaptado de: Wilkinson C, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed International Clinical Diabetic Retinopathy\n         and Diabetic Macular Edema Disease Severity Scales. Ophthalmology. 2003;110:1677-82.\n\n\n\n         Referencias:                                                                                                                                    COMENTARIO\n         • Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.                                                      El edema macular representa la principal causa de disminución de la agudeza visual y ce-\n         • Wilkinson C, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed International Clinical Diabetic Retinopathy and\n           Diabetic Macular Edema Disease Severity Scales.                                                                                               guera, no solo en los pacientes con DM2, sino en la diabetes en general.\n           Ophtha mology. 2003;110:1677-82.\n                                                                                                                                                         El edema macular puede ocurrir en cualquier etapa de la retinopatía diabética. Se define\n                                                                                                                                                         como engrosamiento de la retina y edema que afecta a la mácula, y puede visualizarse\n     44  En   relación con la retinopatía diabética, indique cuál                         de las siguientes afirmaciones                                 mediante un examen de fondo de ojo especializado con visión estereoscópica, angiografía\n         es falsa:                                                                                                                                       con fluoresceína y, más directamente, mediante                         tomografía de coherencia óptica (OCT),\n                                                                                                                                                         una tecnología de imágenes láser no invasiva y de baja energía.\n         A. Debe realizarse examen oftalmológico al diagnóstico de una DM1 para descartar                                                                El efecto del embarazo en la historia natural de la retinopatía diabética se ha abordado en\n             su posible existencia.                                                                                                                      varios estudios; se         ha observado progresión             en el 16% a 85% de los pacientes, y la tasa de\n         B. La pubertad y el embarazo pueden acelerar su progresión.                                                                                     progresión puede acelerarse.\n         C. Las inyecciones intravítreo de agentes antiangiogénicos causan regresión de la\n             neovascularización retiniana.                                                                                                               Referencias:\n                                                                                                                                                         •  Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.\n         D.  La duración de la diabetes se encuentra estrechamente relacionada con la frecuencia                                                         •  Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes\n             y gravedad de la retinopatía diabética.                                                                                                        control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care. 2000;23(8):1084-91.\n\n\n\n         COMENTARIO                                                                                                                                  46  Se    considera que un diabético tiene edema macular diabético (EMD)                                      ligero si tiene\n         Debido a que se estima que la retinopatía tarda al menos 5 años en desarrollarse después de                                                     como hallazgo:\n         la aparición de la hiperglucemia, los pacientes con DM1 deben someterse a un examen ocular                                                      A. Exudados duros lejos del centro de la mácula.\n         inicial completo y en midriasis dentro              de los 5 años posteriores al diagnóstico de diabetes.                                       B. Exudados duros en la mácula, pero sin afectación del punto central.\n         La retinopatía diabética es una complicación vascular altamente específica de la DM1 y la                                                       C. Exudados blandos en la mácula, pero sin afectación\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>DIABETES CARE<|>ORGANIZATION<|>Diabetes Care is a medical journal that publishes research and information related to diabetes and its complications.)\n##\n(\"entity\"<|>WILKINSON C<|>PERSON<|>Wilkinson C is an author who contributed to the proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales.)\n##\n(\"entity\"<|>KLEIN R<|>PERSON<|>Klein R is a researcher who has published extensively on diabetic retinopathy and its complications.)\n##\n(\"entity\"<|>KLEIN BE<|>PERSON<|>Klein BE is a co-author of studies related to diabetic retinopathy.)\n##\n(\"entity\"<|>MOSS SE<|>PERSON<|>Moss SE is a researcher involved in studies on diabetic retinopathy.)\n##\n(\"entity\"<|>DAVIS MD<|>PERSON<|>Davis MD is a medical professional who has contributed to research on diabetic retinopathy.)\n##\n(\"entity\"<|>DEMETS DL<|>PERSON<|>DeMets DL is a statistician who has worked on studies related to diabetic retinopathy.)\n##\n(\"entity\"<|>Ophthalmology<|>ORGANIZATION<|>Ophthalmology is a medical journal that publishes research on eye diseases, including diabetic retinopathy.)\n##\n(\"entity\"<|>DIABETIC RETINOPATHY<|>EVENT<|>Diabetic retinopathy is a complication of diabetes that affects the eyes and can lead to vision loss.)\n##\n(\"entity\"<|>EDEMA MACULAR<|>EVENT<|>Edema macular is a condition associated with diabetic retinopathy that causes swelling in the macula of the eye.)\n##\n(\"relationship\"<|>WILKINSON C<|>DIABETES CARE<|>Wilkinson C is an author of articles published in Diabetes Care, contributing to the field of diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>KLEIN R<|>DIABETES CARE<|>Klein R has authored research articles in Diabetes Care, focusing on diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>KLEIN BE<|>DIABETES CARE<|>Klein BE has contributed to studies published in Diabetes Care regarding diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>MOSS SE<|>DIABETES CARE<|>Moss SE has published research in Diabetes Care related to diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>DAVIS MD<|>DIABETES CARE<|>Davis MD has contributed to articles in Diabetes Care on diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>DEMETS DL<|>DIABETES CARE<|>DeMets DL has worked on statistical analyses for studies published in Diabetes Care regarding diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>DIABETIC RETINOPATHY<|>EDEMA MACULAR<|>Edema macular is a common complication of diabetic retinopathy, leading to vision impairment<|>8)\n##\n(\"relationship\"<|>KLEIN R<|>Ophthalmology<|>Klein R has published research in the journal Ophthalmology on diabetic retinopathy<|>7)\n##\n(\"relationship\"<|>WILKINSON C<|>Ophthalmology<|>Wilkinson C has contributed to research published in Ophthalmology regarding diabetic retinopathy<|>7)\n<|COMPLETE|>"}]}